Back to search

The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia

Data up to Jan 2025

Published1990
Citations54
References25

Total Citations Per Year

Abstract

References (25)

The Metabolic Basis of Inherited Disease

1990 • 4,327 citations

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

1987 • 3,889 citations

Clofibrate and Niacin in Coronary Heart Disease

1975 • 1,660 citations

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

1978 • 1,058 citations

Efficacy and long-term adverse effect pattern of lovastatin

1988 • 338 citations

Clofibrate and niacin in coronary heart disease

1975 • 300 citations

The Biochemical, Clinical, and Genetic Features of Type III Hyperlipoproteinemia

1975 • 260 citations

Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial Hypercholesterolemia

1987 • 215 citations

Therapeutic response to lovasatain (Mevinolin) in nonfamilial hypercholesterolemia - A Multicenter study

1986 • 175 citations

Apolipoprotein E polymorphism and hyperlipidemia.

1984 • 137 citations

Helsinki Heart Study

1988 • 133 citations

Combination Drug Therapy for Familial Combined Hyperlipidemia

1988 • 127 citations

Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.

1984 • 93 citations

Lipid-Lowering Drugs

1987 • 92 citations

Lovastatin therapy in familial dysbetalipoproteinemia: Effects on kinetics of apolipoprotein B

1988 • 83 citations

Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.

1989 • 75 citations

Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.

1989 • 61 citations

Preliminary report: Treatment of type 3 hyperlipoproteinemia with mevinolin

1986 • 51 citations

A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia

1985 • 35 citations

Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II

1986 • 29 citations

Effect of fenofibrate treatment on type III hyperlipoproteinemia

1987 • 28 citations

Treatment of type III hyperlipoproteinemia with four different treatment regimens

1984 • 21 citations

Gemfibrozil in the Treatment of Resistant Familial Hypercholesterolemia and Type III Hyperlipoproteinaemia

1988 • 16 citations

Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia

1985 • 7 citations

Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations.

1980 • 4 citations

Cited By (0)

Loading...
The hypolipidemic effects of lovastatin and clofibrate alone and in combination in… (1990) – Metabolism | Metascience Observatory Explorer